![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/disease_related_1.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/homo_sapiens_1.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/mus_musculus_1.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/danio_rerio_0.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/drosophila_melanogast_0.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/caenorhabditis_elegan_0.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/arabidopsis_thaliana_0.png)
![](/molgen/AnalogYeast/sites/molgen.AnalogYeast/themes/wis_theme/assets/images/flags/escherichia_coli_0.png)
Yeast Systematic Name | Yeast Symbol | SGDID | Analog Name | Analog Description | EC | Organism | Disease | Structure | Uniprot | Human ID | Human Symbol | HHsearch Probability | HHsearch E_value | HHsearch P_value | HHsearch Score | Flag Disease related | Flag Homo sapiens | Flag Mus musculus | Flag Danio rerio | Flag Drosophila melanogaster | Flag Caenorhabditis elegans | Flag Arabidopsis thaliana | Flag Escherichia coli |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
YDR198C | RKM2 | SGDID:S000002606 | SETD3 C14orf154 |
Actin-histidine N-methyltransferase (EC 2.1.1.85) (SET domain-containing protein 3) (hSETD3) |
2.1.1.85 | Homo sapiens | Meier-Gorlin Syndrome 1 |
6icv_b | Q86TU7 | ENSG00000183576 | SETD3 | 100.00 | 4.10E-35 | 3.30E-39 | 308.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR198C | RKM2 | SGDID:S000002606 | SMYD2 KMT3C |
N-lysine methyltransferase SMYD2 (EC 2.1.1.-) (HSKM-B) (Histone methyltransferase SMYD2) (EC 2.1.1.354) (Lysine N-methyltransferase 3C) (SET and MYND domain-containing protein 2) |
2.1.1.354 | Homo sapiens | 4wuy_a | Q9NRG4 | ENSG00000143499 | SMYD2 | 99.30 | 8.60E-17 | 7.20E-21 | 163.00 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YDR198C | RKM2 | SGDID:S000002606 | Smyd1 Bop |
Histone-lysine N-methyltransferase Smyd1 (EC 2.1.1.354) (CD8b-opposite) (SET and MYND domain-containing protein 1) (Zinc finger protein BOP) (m-BOP) |
2.1.1.354 | Mus musculus | 3n71_a | P97443 | 99.10 | 6.60E-15 | 5.60E-19 | 149.80 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YDR198C | RKM2 | SGDID:S000002606 | SET1 KLLA0F24134g |
Histone-lysine N-methyltransferase, H3 lysine-4 specific (EC 2.1.1.354) (COMPASS component SET1) (SET domain-containing protein 1) |
2.1.1.354 | Kluyveromyces lactis | 6chg_c | Q6CIT4 | 96.20 | 3.30E-05 | 2.70E-09 | 64.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR198C | RKM2 | SGDID:S000002606 | SMYD3 ZMYND1 ZNFN3A1 |
Histone-lysine N-methyltransferase SMYD3 (EC 2.1.1.354) (SET and MYND domain-containing protein 3) (Zinc finger MYND domain-containing protein 1) |
2.1.1.354 | Homo sapiens | Cerebellar Ataxia, Nonprogressive, With Mental Retardation,Renal Wilms' Tumor,Hepatocellular Carcinoma |
5v37_a | Q9H7B4 | ENSG00000185420 | SMYD3 | 99.30 | 5.60E-16 | 4.80E-20 | 154.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR198C | RKM2 | SGDID:S000002606 | KMT2D ALR MLL2 MLL4 |
Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.354) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) |
2.1.1.354 | Homo sapiens | Charge Syndrome,Plasma Cell Neoplasm,Cold Agglutinin Disease,Kleefstra Syndrome,Cavernous Sinus Meningioma,Rasopathy,Holoprosencephaly,Hypoplastic Left Heart Syndrome,Leukemia, Acute Myeloid,Dandy-Walker Syndrome,Rubinstein Taybi Like Syndrome,Breast Malignant Phyllodes Tumor,Microphthalmia,Microcephaly,Weaver Syndrome,Sotos Syndrome 1,Alacrima, Achalasia, And Mental Retardation Syndrome,Fanconi Anemia, Complementation Group A,Disease Of Mental Health,Complement Component C1s Deficiency,Chromosome 16p13.3 Deletion Syndrome, Proximal,Mental Retardation, Autosomal Dominant 26,Childhood Medulloblastoma,Lung Squamous Cell Carcinoma,Smith-Magenis Syndrome,Spinocerebellar Ataxia 2,Tetralogy Of Fallot,Peripheral T-Cell Lymphoma,Congenital Disorder Of Glycosylation, Type Ig,Autism Spectrum Disorder,Lymphoma,Kabuki Syndrome 1,Kbg Syndrome,Methylmalonic Acidemia And Homocysteinemia, Cblx Type,Scoliosis,Autosomal Dominant Non-Syndromic Intellectual Disability,Myeloma, Multiple,Medulloblastoma,Isolated Growth Hormone Deficiency Type Iii,Postaxial Acrofacial Dysostosis |
4z4p_a | O14686 | ENSG00000167548 | KMT2D | 96.00 | 4.90E-05 | 4.10E-09 | 64.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR198C | RKM2 | SGDID:S000002606 | KMT5B SUV420H1 CGI-85 |
Histone-lysine N-methyltransferase KMT5B (Lysine N-methyltransferase 5B) (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) |
2.1.1.361,2.1.1.362, | Homo sapiens | Primary Hyperoxaluria,Meier-Gorlin Syndrome 1,Mental Retardation, Autosomal Dominant 51,Autism Spectrum Disorder,Autism,Hyperoxaluria, Primary, Type I |
3s8p_a | Q4FZB7 | ENSG00000110066 | KMT5B | 96.10 | 4.20E-05 | 3.20E-09 | 71.50 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR198C | RKM2 | SGDID:S000002606 | SETD7 KIAA1717 KMT7 SET7 SET9 |
Histone-lysine N-methyltransferase SETD7 (EC 2.1.1.364) (Histone H3-K4 methyltransferase SETD7) (H3-K4-HMTase SETD7) (Lysine N-methyltransferase 7) (SET domain-containing protein 7) (SET7/9) |
2.1.1.364 | Homo sapiens | 1muf_a | Q8WTS6 | ENSG00000145391 | SETD7 | 96.00 | 5.30E-05 | 4.40E-09 | 68.70 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | |
YDR198C | RKM2 | SGDID:S000002606 | clr4 kmt1 SPBC428.08c |
Histone-lysine N-methyltransferase, H3 lysine-9 specific (EC 2.1.1.355) (Cryptic loci regulator 4) (Histone H3-K9 methyltransferase) (H3-K9-HMTase) (HKMT) (Lysine N-methyltransferase 1) (Protein lysine methyltransferase clr4) (PKMT) |
2.1.1.355 | Schizosaccharomyces pombe | 1mvh_a | O60016 | 96.00 | 5.80E-05 | 4.40E-09 | 70.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR198C | RKM2 | SGDID:S000002606 | Kmt5b Suv420h1 |
Histone-lysine N-methyltransferase KMT5B (Lysine-specific methyltransferase 5B) (Suppressor of variegation 4-20 homolog 1) (Su(var)4-20 homolog 1) (Suv4-20h1) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) |
2.1.1.361,2.1.1.362, | Mus musculus | 4bup_b | Q3U8K7 | 96.00 | 5.00E-05 | 3.90E-09 | 70.90 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YDR198C | RKM2 | SGDID:S000002606 | KMT5C SUV420H2 PP7130 |
Histone-lysine N-methyltransferase KMT5C (Lysine N-methyltransferase 5C) (Lysine-specific methyltransferase 5C) (Suppressor of variegation 4-20 homolog 2) (Su(var)4-20 homolog 2) (Suv4-20h2) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) |
2.1.1.361,2.1.1.362, | Homo sapiens | Primary Hyperoxaluria,Hyperoxaluria, Primary, Type I |
3rq4_a | Q86Y97 | ENSG00000133247 | KMT5C | 95.90 | 6.70E-05 | 5.30E-09 | 68.80 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR198C | RKM2 | SGDID:S000002606 | set7 SPCC297.04c |
SET domain-containing protein 7 (EC 2.1.1.-) |
2.1.1.- | Schizosaccharomyces pombe | 5h6z_a | Q9Y7Q6 | 98.10 | 1.10E-09 | 8.80E-14 | 95.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR198C | RKM2 | SGDID:S000002606 | KMT2A ALL1 CXXC7 HRX HTRX MLL MLL1 TRX1 |
Histone-lysine N-methyltransferase 2A (Lysine N-methyltransferase 2A) (EC 2.1.1.354) (ALL-1) (CXXC-type zinc finger protein 7) (Myeloid/lymphoid or mixed-lineage leukemia) (Myeloid/lymphoid or mixed-lineage leukemia protein 1) (Trithorax-like protein) (Zinc finger protein HRX) [Cleaved into: MLL cleavage product N320 (N-terminal cleavage product of 320 kDa) (p320); MLL cleavage product C180 (C-terminal cleavage product of 180 kDa) (p180)] |
2.1.1.354 | Homo sapiens | Childhood Acute Lymphocytic Leukemia,Lymphoblastic Lymphoma,Hypertrichosis,Chronic Neutrophilic Leukemia,Chronic Myelomonocytic Leukemia,Cornelia De Lange Syndrome,Leukemia, Chronic Myeloid,Acute Myeloid Leukemia With T(9;11)(P22;Q23),B-Lymphoblastic Leukemia/Lymphoma,B-Lymphoblastic Leukemia/Lymphoma With Bcr-Abl1,B-Lymphoblastic Leukemia/Lymphoma With Iamp21,Rare Genetic Intellectual Disability,Myeloproliferative Neoplasm,Leukemia,Pancytopenia,Mixed Phenotype Acute Leukemia,Childhood Leukemia,Acute Leukemia,Leukemia, Acute Myeloid,Acute Myeloid Leukemia With 11q23 Abnormalities,Intravascular Large B-Cell Lymphoma,Familial Isolated Trichomegaly,Myelodysplastic/Myeloproliferative Neoplasm,Hematologic Cancer,Leukemia, Acute Lymphoblastic,Ring Chromosome 21,Acute Megakaryoblastic Leukemia Without Down Syndrome,Rubinstein Taybi Like Syndrome,Central Nervous System Leukemia,Monocytic Leukemia,Ring Chromosome,Myeloid Sarcoma,Myeloid Leukemia,Acute Megakaryocytic Leukemia,Acute Monoblastic Leukemia,Colon Leiomyoma,Cytogenetically Normal Acute Myeloid Leukemia,Microcephaly,Hypoxia,Chronic Granulomatous Disease,Alacrima, Achalasia, And Mental Retardation Syndrome,Leukemia, Acute Lymphoblastic 3,Disease Of Mental Health,Cornelia De Lange Syndrome 1,Lymphoma, Non-Hodgkin, Familial,Wiedemann-Steiner Syndrome,Myelodysplastic Syndrome,Hairy Elbows,Acute Promyelocytic Leukemia,Wilms Tumor 1,Kabuki Syndrome 1,Kbg Syndrome,Leukemia, Acute Monocytic,Leukemia, Chronic Lymphocytic,Juvenile Myelomonocytic Leukemia,Autosomal Dominant Non-Syndromic Intellectual Disability,Autism |
5f5e_a | Q03164 | ENSG00000118058 | KMT2A | 96.30 | 1.80E-05 | 1.50E-09 | 66.40 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR198C | RKM2 | SGDID:S000002606 | Kmt5c Suv420h2 |
Histone-lysine N-methyltransferase KMT5C (Lysine-specific methyltransferase 5C) (Suppressor of variegation 4-20 homolog 2) (Su(var)4-20 homolog 2) (Suv4-20h2) ([histone H4]-N-methyl-L-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.362) ([histone H4]-lysine20 N-methyltransferase KMT5B) (EC 2.1.1.361) |
2.1.1.361,2.1.1.362, | Mus musculus | 4au7_a | Q6Q783 | 96.40 | 1.80E-05 | 1.40E-09 | 72.80 | 0 | 0 | 1 | 0 | 0 | 0 | 0 | 0 | |||
YDR198C | RKM2 | SGDID:S000002606 | KMT5A PRSET7 SET07 SET8 SETD8 |
N-lysine methyltransferase KMT5A (EC 2.1.1.-) (H4-K20-HMTase KMT5A) (Histone-lysine N-methyltransferase KMT5A) (EC 2.1.1.361) (Lysine N-methyltransferase 5A) (Lysine-specific methylase 5A) (PR/SET domain-containing protein 07) (PR-Set7) (PR/SET07) (SET domain-containing protein 8) |
2.1.1.361 | Homo sapiens | Meier-Gorlin Syndrome 1 |
3f9x_c | Q9NQR1 | ENSG00000183955 | KMT5A | 96.00 | 4.70E-05 | 3.90E-09 | 64.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR198C | RKM2 | SGDID:S000002606 | A612L |
A612L |
Paramecium bursaria | 2g46_b | O41094 | 96.40 | 1.60E-05 | 1.30E-09 | 63.20 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR198C | RKM2 | SGDID:S000002606 | legAS4 lpg1718 |
legAS4 lpg1718 |
Legionella pneumophila | 5czy_a | Q5ZUS4 | 95.90 | 7.80E-05 | 6.40E-09 | 74.50 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR198C | RKM2 | SGDID:S000002606 | dim-5 29E8.110 NCU04402 |
Histone-lysine N-methyltransferase, H3 lysine-9 specific dim-5 (EC 2.1.1.355) (Histone H3-K9 methyltransferase dim-5) (H3-K9-HMTase dim-5) (HKMT) |
2.1.1.355 | Neurospora crassa | 1peg_a | Q8X225 | 95.80 | 0.0001 | 8.30E-09 | 69.40 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR198C | RKM2 | SGDID:S000002606 | BN1205_038210 TGVEG_216080 |
BN1205_038210 TGVEG_216080 |
Toxoplasma gondii | 6fnd_b | B9Q0K5 | 99.40 | 6.00E-18 | 5.10E-22 | 169.30 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR198C | RKM2 | SGDID:S000002606 | RBCMT |
Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplastic (EC 2.1.1.127) ([Fructose-bisphosphate aldolase]-lysine N-methyltransferase) (EC 2.1.1.259) ([Ribulose-bisphosphate carboxylase]-lysine N-methyltransferase) (PsLSMT) (RuBisCO LSMT) (RuBisCO methyltransferase) (rbcMT) |
2.1.1.127,2.1.1.259, | Pisum sativum | 2h21_b | Q43088 | 99.90 | 4.40E-33 | 3.50E-37 | 288.10 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | |||
YDR198C | RKM2 | SGDID:S000002606 | SETD6 |
N-lysine methyltransferase SETD6 (EC 2.1.1.-) (SET domain-containing protein 6) |
2.1.1.- | Homo sapiens | Familial Colorectal Cancer Type X,Meningioma, Familial |
3qxy_a | Q8TBK2 | ENSG00000103037 | SETD6 | 99.90 | 8.20E-34 | 6.60E-38 | 294.20 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |
YDR198C | RKM2 | SGDID:S000002606 | PFAG_03779 |
PFAG_03779 |
Plasmodium falciparum | 4rz0_a | W7FLI1 | 96.40 | 1.60E-05 | 1.30E-09 | 65.70 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | ||||
YDR198C | RKM2 | SGDID:S000002606 | EZH2 KMT6 |
Histone-lysine N-methyltransferase EZH2 (EC 2.1.1.356) (ENX-1) (Enhancer of zeste homolog 2) (Lysine N-methyltransferase 6) |
2.1.1.356 | Homo sapiens | Skin Melanoma,Retinitis Pigmentosa,Cll/Sll,Chronic Myelomonocytic Leukemia,Melanoma,Breast Myoepithelial Carcinoma,Clear Cell Renal Cell Carcinoma,Diffuse Midline Glioma, H3 K27m-Mutant,B-Cell Lymphoma,Atypical Teratoid Rhabdoid Tumor,Essential Thrombocythemia,Posterior Fossa Ependymoma,Cholangiolocellular Carcinoma,Neuroblastoma,Primary Cutaneous Follicle Center Lymphoma,Leukemia, Acute Myeloid,Secondary Hemophagocytic Lymphohistiocytosis,Bone Marrow Cancer,Transitional Cell Carcinoma,Ezh2-Related Overgrowth,Bladder Cancer,Bile Duct Adenoma,Primary Hyperoxaluria,Ovarian Cancer,T-Cell Acute Lymphoblastic Leukemia,Breast Cancer,Colorectal Cancer,Hepatocellular Carcinoma,Malignant Peripheral Nerve Sheath Tumor,Rhabdomyosarcoma,Weaver Syndrome,Tongue Disease,Sotos Syndrome 1,Gastric Cancer,Breast Adenocarcinoma,Prostate Cancer,Disease Of Mental Health,Cholangiocarcinoma,Rhabdoid Cancer,Fragile X Syndrome,Lymphoma, Non-Hodgkin, Familial,Beckwith-Wiedemann Syndrome,Esophageal Cancer,Myelodysplastic Syndrome,Diffuse Large B-Cell Lymphoma,Ewing Sarcoma,Mantle Cell Lymphoma,Splenic Marginal Zone Lymphoma,Tongue Squamous Cell Carcinoma,Acute Promyelocytic Leukemia,Follicular Lymphoma,Ovarian Clear Cell Carcinoma,Nasopharyngeal Carcinoma,Lymphoma,Brain Glioma,Kabuki Syndrome 1,Juvenile Myelomonocytic Leukemia,Autosomal Dominant Non-Syndromic Intellectual Disability,Rett Syndrome,Myelofibrosis,Myeloma, Multiple,Medulloblastoma,Melanoma, Uveal,Childhood Acute Myeloid Leukemia,Lung Cancer,Hyperoxaluria, Primary, Type I,Pancreatic Cancer,Polycythemia Vera |
4mi5_a | Q15910 | ENSG00000106462 | EZH2 | 96.60 | 7.90E-06 | 6.30E-10 | 74.30 | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 |